Healthcare provider profile · identity verified

Brooke E Bohnstedt, NP-C

Nurse Practitioner · FORT WAYNE, IN · NPI 1588067300

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	298	77
Atorvastatin Calcium	Atorvastatin Calcium	199	63
Amlodipine Besylate	Amlodipine Besylate	182	53
Lisinopril	Lisinopril	169	48
Pantoprazole Sodium	Pantoprazole Sodium	123	38
Metformin Hcl	Metformin Hcl	118	33
Bupropion Xl	Bupropion Hcl	115	29
Omeprazole	Omeprazole	110	38
Losartan Potassium	Losartan Potassium	105	28
Hydrochlorothiazide	Hydrochlorothiazide	93	26
Meloxicam	Meloxicam	87	39
Metoprolol Succinate	Metoprolol Succinate	78	15
Metformin Hcl Er	Metformin Hcl	75	19
Escitalopram Oxalate	Escitalopram Oxalate	74	21
Buspirone Hcl	Buspirone Hcl	73	20
Citalopram Hbr	Citalopram Hydrobromide	73	19
Simvastatin	Simvastatin	72	16
Trazodone Hcl	Trazodone Hcl	67	20
Pravastatin Sodium	Pravastatin Sodium	66	23
Rosuvastatin Calcium	Rosuvastatin Calcium	64	20
Famotidine	Famotidine	63	24
Glimepiride	Glimepiride	63	14
Duloxetine Hcl	Duloxetine Hcl	59	13
Montelukast Sodium	Montelukast Sodium	58	17
Mounjaro	Tirzepatide	58	12
Fluticasone Propionate	Fluticasone Propionate	54	27
Gabapentin	Gabapentin	52	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	18
Sertraline Hcl	Sertraline Hcl	50	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	23
Furosemide	Furosemide	45	13
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	24
Allopurinol	Allopurinol	41	12
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	13
Celecoxib	Celecoxib	34	12
Fluoxetine Hcl	Fluoxetine Hcl	34	11
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Ozempic	Semaglutide	33	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	32	suppressed
Carvedilol	Carvedilol	29	suppressed
Jardiance	Empagliflozin	29	suppressed
Prednisone	Prednisone	28	27
Soliqua 100-33	Insulin Glargine/Lixisenatide	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Estradiol	Estradiol	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Atenolol	Atenolol	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Primidone	Primidone	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Baclofen	Baclofen	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Azithromycin	Azithromycin	16	16
Donepezil Hcl	Donepezil Hcl	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Linzess	Linaclotide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	12
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Eliquis	Apixaban	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error